Effect of Different Irrigation Protocols on Postoperative Endodontic Pain and Inflammation
Condition(s) studied
Investigational drug(s) / intervention(s)
EDTA: 17% EDTA as a final rinse after instrumentaion (sequential chelation)
Etidronate: 9% HEBP as a final rinse after instrumentation (sequential chelation)
clodronate: 0.26 M (7.6%) clodronate as a final rinse after instrumentation (sequential chelation)
Etidronic acid /sodium hypochlorite: (2.5% NaOCl + 9% HEBP) during instrumentation and as a final rinse after instrumentation (continous chelation)
clodronate + sodium hypochlorite: 2.5% NaOCl + 0.26 M (7.6%) clodronate during instrumentation and as a final rinse after instrumentation (continuous chelation)
Study summary
This study aims to improve the postoperative endodontic outcome by assessing the effect of different irrigants on postoperative endodontic pain and their anti-inflammatory effects.
Eligibility
Primary outcome measure(s)
- Postoperative pain assessment using Numerical Rating Scale NRS — Postoperative pain was assessed after 6, 12, 24, 48 hours and 7 days after the first visit using a numerical rating scale NRS
Postoperative pain is assessed after 6, 12, 24, 48 hours and 7 days after the first visit using a numerical rating scale NRS where the patient is asked to select the number representing the pain intensity as follow '0' representing no pain and '10' being the worst pain - MMP-9 levels in periapical tissues using periapical fluid samples using a commercially available ELISA kit — After the final rinse (S1) and after one week (S2).
MMP-9 levels in periapical tissues are quantified using a commercially available ELISA kit applied on the periapical samples that will be collected after the final rinse (S1) and after one week (S2).
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Faculty of dentistry, suez canal university | Ismailia | Egypt |
More Suez Canal University trials in Egypt
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07116252 on ClinicalTrials.gov ↗ ← All trials in Egypt